When DEA Diversion Investigators arrive at your veterinary practice, you’ll probably focus on one thing: getting through the inspection. You’ll provide the required records for review, let them examine inventory reports, inspect security measures, audit controlled substances, and ask questions about procedures and operations. Eventually, they leave. The inspection appears to be over.
In reality, that’s just the beginning.
You - like many veterinarians - assume that if the investigators didn’t mention any major concerns during their visit, there’s nothing to worry about. Or you may worry that every DEA inspection automatically means penalties or disciplinary action. Neither assumption is accurate.
The post-onsite investigation period is when investigators complete their analyses and audits, review documents and observations more closely, determine whether violations occurred, and decide what corrective actions may be needed. After the inspection you may be looking at outcomes ranging from no action at all to formal administrative proceedings that threaten your authorization to handle controlled substances.
A DEA inspection has one goal: evaluating whether you are complying with the Controlled Substances Act and related regulations. Investigators’ base their conclusions on examinations of:
Controlled substance inventories
Purchasing records
Dispensing, administration, disposal/destruction logs and records
Theft and loss reports
Physical security measures and employee access controls
Policies and procedures related to controlled substances
Results of drug inventory accountability audits, including your explanations regarding any discrepancies
Interview answers from you and your employees
Following the on-site inspection, Diversion Investigators generally spend additional time researching background information, verifying audit calculations, and discussing findings with supervisors. They may contact the practice for additional documentation or clarification before reaching final determinations, and conducting the closing discussion with you to explain their findings.
In TITAN Group’s many years of helping veterinarians deal with inspection issues, our compliance experts have found that bad inspection outcomes are due to issues that vets never realized existed in their practices:
Biennial inventories that were inaccurate, never completed or cannot be located.
Controlled substance logs that do not reconcile with purchasing records.
Missing documentation for drug transfers between locations.
Expired controlled substances improperly disposed of and not documented.
Inventory discrepancies that were noticed but never investigated.
Poor drug storage and handling practices that sacrifice convenience over security
In many cases, these deficiencies developed gradually over years. Sloppy or casual practices were overlooked. Small documentation errors were ignored because there were other priorities to deal with. Training is put on the back burner due to cost or lack of convenient timing.
The result: many veterinarians don’t realize they have problems until DEA investigators point them out – and explain the consequences.
Many veterinary inspections conclude with no significant findings and no enforcement action. Investigators find that the practice maintains adequate controls against diversion, keeps accurate records, and complies with applicable DEA requirements. While minor observations or recommendations may be provided, the inspection is typically closed without further action.
While a clean inspection doesn’t guarantee future success, it’s a sign that the practice is maintaining a compliance-positive culture.
When investigators identify relatively minor deficiencies (like an improperly labeled record, a missing signature, or records not separated properly), you may only receive verbal warnings.
Multiple deficiencies (like lack of readily retrievable records, incomplete inventories, missing documentation), however, could result in more formal warnings like a Letter of Admonition (LOA). While the specific content varies, these letters typically describe the violations, the regulatory requirements involved, and give you 30 days to respond in writing to explain how the problems were corrected and what changes will be made to prevent similar problems in the future.
While the LOA may seem like a slap on the wrist, don’t be fooled: it’s now part of your registration history. A pattern of noncompliance during future inspections or other problems stemming from documented violations (e.g., an employee drug theft tied to improper security you were warned about) may lead to more significant administrative actions later. And failing
to respond to the LOA is itself a violation that could entail more serious sanctions.
An LOA should be seen as an opportunity to improve systems before deficiencies escalate into enforcement issues.
Numerous serious violations – or failure to gain your compliance through previously-issued LOAs – could earn you a Memorandum of Agreement (MOA). An MOA is essentially a negotiated settlement between you and the DEA. The DEA allows you to keep your registration if you agree to specific corrective measures and ongoing oversight.
Typically enforced for a three-year period, an MOA may require you to:
Upgrade controlled substance security systems
Conduct periodic self-audits
Implement enhanced recordkeeping systems
Submit periodic reports to DEA
Participate in compliance training
There may be follow-up inspections or document reviews to ensure compliance with the agreement’s terms. Fail to comply with the MOA? You could be looking at harsher penalties – including removal of your DEA registration.
In some cases where violations were significant and serious, DEA may combine the MOA with civil monetary penalties. The current penalty is $19,246 per violation.
Missing inventories and other records? That’s $19,246 per missing document.
Combined with other compliance violations means the dollars add up quickly. To impose financial fines, DEA investigators partner with the United States Attorney’s Office (DEA is part of the U.S. Department of Justice) in your district.
Now you’re facing fines, DEA’s compliance requirements, any additional compliance or punishment conditions imposed by the USAO, personal attorney’s fees, public image damage (these cases often show up in the news), and other practice disruptions. And if you think retiring and closing your practice gets you out of trouble, think again: the USAO may still decide to pursue a court-imposed judgement to obtain payment of the fines no matter where you are.
For truly egregious violations – or a continuing failure to meet compliance requirements - continued possession of your DEA registration may be seen as against public health and safety.
DEA could choose to impose one of its most significant administrative enforcement tools: the Order to Show Cause (OTSC). Now is the time to hire experienced legal and/or compliance expert.
An OTSC is a formal legal proceeding through which DEA proposes to revoke, suspend, or deny a registration. Receiving an OTSC does not automatically result in loss of your registration, but you’re now on the way to that outcome.
You will have the right to request a hearing before a DEA administrative law judge, present evidence, challenge DEA’s allegations, and demonstrate why their registration should be maintained. But unlike a criminal trial that could hinge on “reasonable doubt”, the OTSC is a civil proceeding so DEA simply needs a “preponderance of evidence” in order to win.
If DEA investigators determine that your handling of controlled substances presents an imminent danger to public safety, they could seek an Immediate Suspension Order (ISO).
Factors that may support an ISO include:
Significant diversion of controlled substances
Fraudulent prescribing or prescribing practices directly attributed to public harm
Intentional record falsification
Dangerous lack of care in preventing drug diversion
If granted, the ISO you receive means you automatically lose your authorization to purchase, prescribe, dispense, administer, or otherwise handle controlled substances.
Typical DEA inspections are administrative in nature, but be aware: investigators are trained to recognize indicators of criminal activity.
Signs of drug diversion and theft schemes, falsification of records, illegal drug distribution, financial irregularities associated with controlled substances, and other inspection evidence could turn their regulatory case into a criminal investigation. You could then be facing criminal prosecution, loss of professional licensing, damage to your public credibility, and even imprisonment.
While most veterinary inspections never reach this stage, registrants should never forget that intentional misconduct is treated very differently from ordinary compliance deficiencies.
Many veterinarians focus exclusively on the immediate outcome of an inspection. However, the long-term impact can be equally important.
Applying for a new registration or renewing your existing registration includes questions regarding prior disciplinary actions involving professional licenses and DEA registrations. That means DEA may conduct additional reviews of your activity before approving a new or renewed application.
This is another reason why addressing deficiencies promptly and demonstrating good-faith corrective efforts is so important.
The outcome of your DEA inspection is rarely determined on the day investigators walk through the door. More often, it is determined by the quality of the compliance systems you’ve built during the months and years beforehand.
Vets with peace of mind have practices that perform smart recordkeeping, perform routine audits, investigate discrepancies promptly, train staff effectively, and implement strong diversion-prevention controls. Others feel anxiety when they think about DEA knocking on their door.
At TITAN Group, we’ve spent the last nine years helping hundreds of vets from coast to coast implement practical solutions that reduce risk before deficiencies become enforcement actions. With TITAN on your side, you’ll send a clear message: my practice is committed to responsible controlled substance management. Learn more about our services and speak to our team of experts.